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We have synthesized capsid proteins of human papillomavirus types 6 (HPV 6) and 16 (HPV 16) in fission yeast Schizosac- 
charomyces pombe and produced virus-like particles (VLP). The capsid proteins were localized in the nucleus by indirect 
immunofluorescence and cell fractionation analyses. The VLP were produced in both yeast clones synthesizing L1 alone 
and L1/L2 and purified by sulfato-cellulofine chromatography. Electron microscopic examination showed that these VLP 
were similar in structure to native HPV particles. Two HPV 16 L1 variants (16 B27L1 and 16 T3L1), isolated from benign 
cervical samples, produced many more (68- and 14-fold) VLP than the prototype L1 (16 PL1) derived from cervical carcinoma. 
Coexpression of the HPV 6 L2 protein with 6 L1 and 16 B27L1 proteins increased the production level of the VLP four- and 
twofold, respectively. The L2 was not detected in the VLP purified with sulfato-cellulofine column, although the L2 was 
purified in the same fraction containing HPV 6 and 16 B27-VLP by size-fractionation using Sepharose column. Interaction 
between 6 L2 and 6/16 L1 proteins was not detected by the coimmunoprecipitation assays with either L1 or L2 antibodies. 
These results suggest that the L2 is not incorporated into the VLP synthesized in yeast. © 1995 Academic Press, Inc. 
INTRODUCTION 
Papillomaviruses infect the epithelia of a wide variety 
of animals and generally induce benign proliferative le- 
sions at the site of infection. Some types of papillomavi- 
rus can induce malignant tumors. More than 70 types of 
human papillomavirus (HPV) have been isolated and 
some of these HPVs are etiological factors for various 
warts in the skin or the mucosal epithelium. Each HPV 
type has a strong host cell specificity for infection. Among 
the mucosal types, HPV 6 and HPV 11 are associated 
with benign warts, while the HPV 16 and the HPV 18 
are associated with anogenital cancer and its precursor 
lesions (zur Hausen, 1991). Although HPV 6 or HPV 11 
are generally benign in adults, they can also induce more 
severe lesions in children such as juvenile laryngeal pap- 
illomatosis (Strong et aL, 1979). This disease is extremely 
resistant to any clinical treatment. Therefore, it is im- 
portant o establish human prophylactic vaccines against 
HPV 6 and 11, as well as the malignant types of HPV 
such as HPV 16 and 18, to prevent these viral infections. 
The study of these viral structural proteins has pro- 
gressed less than that of the oncoproteins of these vi- 
ruses, because of the lack of a suitable propagation sys- 
tem for HPV virions in vitro. 
Immunization with BPV or HPV 11 virions has elicited 
~To whom correspondence and reprint requests should be ad- 
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antibodies in animals which inhibit the infectivity of these 
viruses for cultured cells (Dvoretzky et aL, 1980) or for 
xenograft issue (Ghim et al., 1991). Some of these neu- 
tralizing antibodies arising in these animals recognized 
conformational epitopes of the viral capsid proteins 
(Christensen et al., 1990). Neutralizing antibodies could 
also be generated by immunization with bacterially de- 
rived BPV L1 and L2 proteins, but titers of these antibod -
ies were very low (Pilacinski et al., 1984; Jin et aL, 1989). 
Therefore, immunization with the native capsid structure 
of HPV seems to be essential to produce effective vacci- 
nation against human papillomaviruses. 
Native virions of papillomaviruses are nonenveloped 
50- to 60-nm spherical structures composed of 72 penta- 
meric capsomeres in icosahedral symmetry. Each capso- 
mere is composed of five L1 molecules and form a virion 
shell with a T-- 7 symmetrical attice (Baker et al., 1991). 
Several groups have established systems for making vi- 
rus-like particles (VLP) which resemble native HPV parti- 
cles but lack viral DNA. HPV 16 and HPV 1 particles have 
been produced in a vaccinia virus system (Zhou et al., 
1991a; Hagensee eta/., 1993) and HPV 11, HPV 16, and 
H PV 33 particles in a baculovirus system (Kirnbauer et al., 
1992; Rose et al., 1993; Volpers et al., 1994). Conforma- 
tionat epitopes present in native HPV 11 infectious virions 
were also present on the baculovirus-produced HPV 11 
VLP and reacted with sera obtained from individuals with 
condyloma acuminata (Rose et al., 1993). These VLP may 
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substitute for native virions of human papillomaviruses as 
prophylactic vaccines for humans. However, using these 
in vitro production systems, the production level of the 
VLP from HPV 16 was still very low (Kirnbauer et al., 1992). 
Kirnbauer et al. (1993) recently reported that two iso- 
lates of HPV 16, which shared a nonconservative change 
0f histidine 202 to aspartic acid in the L1 sequence, were 
able to produce VLP much more efficiently than prototype 
HPV 16 in a baculovirus system. We have recently iso- 
lated 10 HPV 16 L1 variants from clinically obtained cervi- 
cal samples in UK and Trinidad containing high copy 
numbers of HPV 16 genomes (Pushko et al., 1994). All 
these variants had aspartic acid at amino acid 202 of L1. 
Both vaccinia virus and baculovirus systems are ex- 
pensive and require laborious manipulations to increase 
theyield of VLP. An expression system using yeast would 
be an attractive alternative to these higher eukaryotic 
systems if correctly assembled capsid proteins could be 
obtained. We expressed variant HPV 16 L1 capsid genes 
as well as the prototype L1 genes of HPV 16 and HPV 6 
in fission yeast Schizosaccharomyces pombe and char- 
acterized the structural function of each capsid protein. 
Two HPV 16 L1 variants and the HPV 6 L1 assembled 
t0 form VLP resembling native capsids in contrast to the 
prototype L1 of HPV 16. The HPV particles produced in 
yeast would be good candidates as prophylactic vac- 
cines for humans. 
MATERIALS AND METHODS 
Preparation and isolation of recombinant yeast 
Fragment DNA coding L1 protein (nt 5789 to 7291) and 
L2 protein (nt 4554 to 5802) of HPV 6 were generated by 
p01ymerase chain reaction (PCR) with PFU polymerase 
(Stratagene). Both genes were cloned into BamHI-Xhol 
sites of the pBSK (Stratagene) and in NcoI-EcoRI sites 
of pET vector (Novagen), respectively. The PCR primers 
for HPV 6 L1 and L2 were designed to contain BamHI-  
Xhol and NcoI-EcoRI restriction sites for the L1 and L2 
genes of the HPV 6, respectively. The sequence of these 
primers are as follows, HPV 6 L1 primers, 5'-primer, 5'- 
GGGGATCCATGTGGCGGCCTAGCCGACAG-3' and 3'- 
primer, 5'-CCCTCGAGTTACCq-I--i-i-AG-i-i-FI-G G CG CG-3', 
HPV 6 L2 primers, 5'-CCCATGGCACATAGTAGGGCC- 
0GACGACG-3' and 5'-GGGAATI-CCTAGGCCGCCACA- 
TOTGAAAA-3'. The cutting sites of each restriction en- 
zyme on these primers are underlined. A prototype and 
two mutant ypes of L1 capsid genes of HPV 16 (B27L1 
and T3L1) had been generated by PCR were cloned into 
pBSK vector (Pushko et al., 1994). All these capsid genes 
were sequenced with a T7 sequence kit (Pharmacia) and 
were confirmed to have full coding sequences. All capsid 
genes were cut out from all the recombinant pBSK and 
pET and introduced into yeast expression vectors pREP 
3 and pREP 4 containing thiamine-repressible promoter 
(Maundrell, 1993). HPV 16 L1 was cloned at Bali and 
Sail sites of pREP 3 and the HPV 16 L2 was cloned at 
the same site of pREP 4. The HPV 6 L1 was cloned in 
BamHI-Xhol sites of pREP 4-20 and a fragment of HPV 
6 L2 gene was cloned at Ball site of pREP 3-20 by blunt 
end ligation. All the constructs of the recombinant genes 
used in this study are shown in Fig. 1. 
The leu- and ura-auxotrophic mutant of S. pombe was 
transformed with the recombinant plasmids. We intro- 
duced both L1 and L2 genes via pREP 3 (leu) and pREP 
4 (ura) vectors into a mutant yeast (leu-, ura-) by allowing 
the recombinant clone to grow selectively in minimal 
essential medium without leucine and uracil. 
Immunoblot analysis 
Yeast cells were suspended in yeast lysis buffer (50 
mM Tris-CI, pH 8.0, 0.1% Triton X-100, 0.5% SDS), boiled 
for 2 min, and broken with glass beads (0.45-0.60 mm, 
Sigma) using a.strong vortex for four periods of 1 min 
intermittently cooling on ice. Total cell extracts were ob- 
tained after centrifugation at 10,000 g for 10 min. Equal 
amounts of denatured protein were loaded onto 10% 
SDS-polyacrylamide mini gels and run at 100 Vfor 1 hr. 
The proteins were transferred onto nitrocellulose mem- 
brane (Hybond-O, Amersham) using electroblot appara- 
tus (Bio-Rad) and incubated in PBS-M buffer (PBS con- 
taining 5% dried milk and 1% fetal bovine serum) at 37 ° 
for 30 min. After washing once with PBS, the membrane 
was incubated with PBS-M containing the appropriate 
antibody diluted 1=250 and incubated at 4 ° overnight. 
After three 20-min washes with PBST (PBS containing 
0.1% Tween 20), the membrane was incubated in an anti- 
mouse-peroxidase conjugate diluted 1=1000 in PBST at 
room temperature for 40 min, followed by three further 
washes of the membrane with PBST. Protein signals 
were detected by chemoluminescence using ECL West- 
ern blotting detection reagents (Amersham) according to 
the manufacturer's instructions. 
Indirect immunofluorescence 
Thirty milliliters of cultured yeast induced to express 
the introduced genes was fixed with 3% formaldehyde 
and 0.2% glutaraldehyde in PEM buffer (100 mM PIPES, 
pH 7.4, 1 mM EDTA, 1 mM MgSO4) at 30 ° for 60 min. The 
cells were digested with 0.25% mutanase and 0.0625% of 
zymolase (20000 U Seikagaku Kogyo). Protoplasts were 
prepared by the method of Hagan and Hyams (1988). 
Permeabilized protoplasts were pelleted and resus- 
pended in 5-7 vol of PEMBAL solution (1% bovine serum 
albumin, 0.1% sodium azide, 100 mM lysine hydrochlo- 
ride in PEM buffer) containing the appropriately diluted 
antibodies. The optimum dilution of each antibody was 
determined by preliminary experiments. Following 16 hr 
incubation, the cells were washed three times in PEM- 
BAL and resuspended in 5-7 vol of fluorescent labeled 
anti-mouse antibody at 2% in PEMBAL Incubation of the 
secondary antibody was for 4 hr and followed by three 
washes in PEMBAL For observation, cells were air dried 
128 SASAGAWA ET AL. 
onto poly-L-lysine-coated coverslips and inverted onto 
glass slides. The stained samples were examined on a 
Con-focal Fluorescence Imaging System MRC-500 Bio- 
Rad microscope. 
Cell fractionation analysis of S. pombe 
Yeast cells induced for expression of the introduced 
genes were cultured in 1000 ml of minimal low glucose 
medium for 16 hr at 30 °, centrifuged at 800 g for 5 min, 
and resuspended in 50 ml of 50 mM potassium phos- 
phate buffer (pH 6.5) containing 25 mM EDTA. After re- 
centrifugation, the pellet was resuspended with 10 ml of 
KKC buffer (20 mM potassium phosphate buffer, pH 6.5, 
800 mM KCi, 0.1 mM CaCI2) containing 5 mg/ml of Novo- 
Zym 234 (Novo Nordisk Biolabs) and then incubated at 
32 ° for 30 min to digest the cell walls. The sample was 
then layered onto a 35-ml cushion of cold KKC/G (KKC 
buffer containing 10% glycerol) and centrifuged at 1000 
g for 10 min at 4 ° . The supernatant containing small 
particles of cell wall debris was removed and later ana- 
lyzed as a membrane fraction of yeast. The pellet was 
resuspended in 1 ml of cold KKC/G and diluted with 7 
ml of hypotonic KC buffer (20 mM potassium phosphate 
buffer, pH 6.5, 0.1 mM CaCI2) supplemented with prote- 
ase inhibitors, 0.5 mM PMSF, 1 mg/ml leupeptin, 1 mg/ 
ml aprotinin, and 1 mg/ml pepstatin (Sigma). Separation 
of the cytoplasm from the nucleus was achieved by add- 
ing Nonidet P-40 to the sample to a final concentration 
of 0.1%. Five milliliters of the sample was then layered 
onto a 25-ml cushion of KM/F (20 mM potassium phos- 
phate buffer, pH 6.5, 2 mM MgCI2, 10% Ficoll) and centri- 
fuged at 26,900 g, 4 ° for 60 min, separating the cyto- 
plasmic and nuclear fractions in the supernatant and 
pellet, respectively. Ten micrograms of protein from each 
fraction was subjected to immunoblot analysis. 
Purification of virus-like particles by sulfato-cellulofine 
chromatography and preparation of the sample for 
electron microscopy 
Yeast cells induced for synthesis of the capsid proteins 
were harvested from 1600 ml of cultures by centrifugation 
and resuspended in 20 ml of PBS. The yeast cells were 
broken mechanically with glass beads in a cell-breaking 
machine (Melsungen AG, Braun) for 2 min with repeated 
cooling. The supernatant was obtained after centrifuga- 
tion at 10,000 rpm, 4 ° for 10 min using a Sorvall SS 34. 
After filtration with an 0.45-#m filter, this cell extract was 
applied onto a sulfato-cellulofine (Seikagaku Kogyo) col- 
umn (2.6 x 13 cm) equilibrated with 0.15 M PBS (10 mM 
phosphate buffer, 0.15 M NaCI). After washing with 5X 
bed volumes of 0.15 M PBS followed by the same volume 
of 0.5 M PBS (10 mM phosphate buffer, 0.5 M NaCI), the 
fraction containing capsid proteins was eluted with 2 M 
PBS (10 mM phosphate buffer, 2 M NaCI). The eluate 
was then applied to a Sepharose CL 4B column (2.6 x 
100 cm) equilibrated with 2 M PBS and a first peak frac- 
tion of this column was collected. 
To examine the yield of VLP i.n different yeast clones, 
each 0.5 ml of the VLP sample purified with a sulfate- 
cellulofine column was concentrated with a Ultra CL-filter 
30,000 NMWL (Millipore) and then negatively stained for 
electron microscopic examination. 
Transmission electron microscopy 
Two microliters of the sample was placed onto a glow- 
discharged carbon-coated grid and allowed to absorb 
for about 1 min in a moist chamber; it was then washed 
with 10 drops of 1% aqueous potassium phosphotungstic 
acid (pH 7.0) or 1% aqueous uranyl acetate. The high 
resolution electron micrographs were recorded using an 
(Philip EM 301 A and Zeiss 10 C) electron microscope 
at x34,000- magnification. 
Purification of virus-like particles with equilibrium 
gradient centrif~gation 
Cell extract was obtained from 10 liters of yeast culture 
by the same procedure described above. After adding 
cesium chloride (CsCI) to the cell extract to a density of 
1.30 g/ml, the sample was centrifuged at 27,000 rpm for 
40 hr at 10 ° using a Beckman SW 28 rotor. Thirty fractions 
were collected and checked for presence of L1 protein by 
immunoblot analysis. The fractions containing L1 protein 
were diluted in PBS and centrifuged at 35,000 rpm for 4 
hr at 4 ° using Beckman SW 41 rotor. The pellet was 
resuspended in buffer A (Tris-HCI, pH 7.5, 2 M NaCI, 2 
mM MgCI2, 15 mM mercaptoethanol) by rotation over- 
night at 4 ° . To obtain purer sample, the fractions con- 
taining L1 protein were repurified by CsCI gradient ultra- 
centrifugation for 24 hr. 
RESULTS 
Synthesis of HPV 6 and HPV 16 capsid genes in ,9. 
pombe 
To test the ability for self-assembly in vivo, we con- 
structed yeast recombinant REP vectors and synthesized 
different capsid proteins from HPV 6 and HPV 16 in fission 
yeast S. pombe under the control of a thiamine-repressible 
promoter (Tommasino and Maundrell, 1991; Maundrell, 
1993). Three different HPV 16 L1 (PL1, B27L1, and T3Li 
and HPV 6 L1 (6 L1) genes were tested (Fig. 1). The PL1 
was derived from the prototype H PV 16 DNA isolated from 
a cervical carcinoma (Durst eta/., 1983) and the B27L1 and 
T3L1 were isolated from two benign cervical cell samples 
containing high copy number of viral genomes (Pushko et 
al., 1994). The B27L1 and T3L1 contained several point 
mutations compared with the prototype L1 sequence (Seed- 
orf et al., 1985), including the aspartic acid at position 202, 
as reported by Kirnbauer et al. (1993). 
HPV 6 L1 (lane 3 in Fig. 2C) and PL1, B27L1, and T3L1 
of HPV 16 (lanes 1-6 in Fig. 2A) proteins were detected 
as a 57-kDa band in immunoblot analysis of induced cul- 
tures. The size of the band was the same as that of HPV16 
L1 synthesized in insect cells (lane 7 in Fig. 2A). No bands 
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Fie. 1. Constructs of the yeast recombinant vectors used in this study. The L1 capsid genes of HPV 16 and L1/L2 genes of HPV 6 were introduced 
in yeast vectors pREP 3 and pREP 4. The amino acid changes inthe variant L1 genes of HPV 16, B27L1, and T3L1 are indicated. Nonconservative 
changes are underlined. 
were detected in the samples which were not induced for 
expression of L1 proteins (lane 2 in Fig. 2C) nor in normal 
yeast (lane 8 in Fig. 2A and lane 1 in Fig. 2C). Several 
smaller bands (less than 49 kDa) were often observed in 
three different L1 proteins of HPV 16 and are probably 
degradation products of L1. No differences were observed 
in size or level of expression between variant (B27L1 and 
T3L1) and prototype (PL1) L1 proteins of HPV 16 (lanes 1, 
3, and 5 in Fig. 2A). The HPV 6 L2 protein was detected 
as a 75-kDa band in every sample expressing the 6 L2 
gene (lanes 4, 5, and 6 in Fig. 2B). None of these bands 
were detected in the other clones containing no 6 L2 
(lanes 1, 2, and 3 in Fig. 2B) or in the same clones not 
induced for expression of the L2 gene (data not shown). 
Local izat ion of the capsid proteins 
Native virions of human papil lomaviruses are known to 
be propagated in the nucleus of infected cells. It was 
reported that both L1 and L2 proteins of HPV 16 and 
HPV 1 were localized in the nucleus (Zhou eta/., 1991b; 
Hagensee et al., 1993). All the capsid proteins are pre- 
sumed to be directed from the cytoplasm to the nucleus 
immediately after translation (Zhou et al., 1991 b), The nu- 
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FIG. 2. Western blot analyses for expression of HPV 6/16 capsid genes in yeast. (A) HPV 16 L1 was detected as a 57-kDa b nd in lanes 1-7 
with anti-16 L1 antibody (Camvir-1). Lane 1, 16 PL1; lane 2, 16 PL1/6L2; lane 3, 16 B27L1; lane 4, 16 B27L1/6 L2; lane 5, 16 T3L1; lane 6, 16 T3L1/ 
6 L2; lane 7, HPV 16 PL1 expressed in the insect cells infected with the recombinant baculovirus. Lane 8, normal yeast. (B) HPV 6 L2 was detected 
as a 75-kDa band in lanes 4-6 with anti-HPV 6 L2 antibody (3F7). Lane 1, HPV 6L1; lane 2, HPV 16 PL1; lane 3, HPV 16 B27L1; lane 4, HPV 6L1/ 
6L2; rane 6, HPV16 PL1/6L2; lane 6, HPV16 B27L1/6L2. (C) HPV 6 L1 was detected as a 57-kDa band i  lane 3 with anti-HPV 33 L1 antibody. Lane 
1, normal yeast; lane 2, HPV 6L1/6L2, noninduced; lane 3, HPV 6 L1/6 L2, induced. 
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FIG. 3. Localization of L1 and L2 capsid proteins by indirect immunofiuorescence. Yeast cells induced for expression f HPV 6L1/L2 genes were 
stained with a neutralizing antibody against HPV 11 (B2) (A), with anti HPV6 L2 (3F7) (B), and with a control antibody (anti-HPV 16 E2 protein) (C). 
Strong L1 protein signals are observed in the nucleus of the yeast (A). L2 is predominantly stained in the nucleus but spotty staining is also seen 
in the cytoplasm (B). No signals are observed with a control antibody (C). 
clear localization of the L1 protein may be important for 
viral capsid assembly or for maturation of viral particles. 
To investigate this in a yeast system, we carried out an 
indirect-immunofluorescence analysis on each clone us- 
ing the L1 or L2 monoclonal antibodies. After induction 
for expression of the introduced capsid genes, cells were 
stained with appropriate antibodies. In the HPV 6 L1 clone, 
30-50% of the cells were positively stained with the neu- 
tralizing monoclonal antibody (B2) against HPV 11 which 
can prevent infection with HPV 11 (Christensen et aL, 
1990). Only nuclear or perinuclear staining was observed 
in 10-30% of these positively stained cells. The other cells 
were stained in both the nucleus and the cytoplasm, with 
nuclear staining still more predominant than cytoplasmic 
(Fig. 3A). However, nuclear staining was not observed with 
the other anti-HPV 11 antibody (H3) or with an anti-HPV 
33 L1 antibody which could detect denatured HPV 6 L1 
protein by Western blot analysis (Fig. 30). 
HPV 6 L2 protein was also detected in the yeast coex- 
pressing HPV 6 L1 and 6 L2. The frequency and intensity 
of the L2 staining on these cells was similar to that of 6 
L1. The L2 protein was detected in both nucleus and 
cytoplasm, although the nuclear staining was dominant 
in more than half of the cells (Fig. 3B). The staining pat- 
tern of L1 was diffuse (Fig. 3A) while that of L2 looked 
spotty and irregular (Fig. 3B). No staining was observed 
in control yeast cells with any L1 and L2 antibodies nor 
a control antibody (Fig. 30). 
For HPV 16 the L1 signals were localized in either the 
nucleus or the perinucleus of all recombinant clones ex- 
pressing PL1, B27L1, or 3T L1 proteins, and the staining 
pattern was similar in all these clones (data not shown). 
HPV 6 L2 expression was also observed in all chimeric 
clones containing 16 L1 and 6 L2. The staining pattern of 
the L2 protein in these chimeras was identical to that of 
the yeast containing HPV 6 L1/6 L2 (data not shown). 
To confirm the nuclear localization of these capsid 
proteins, we fractionated cell components using a Ficoll 
separation method and compared the expression level 
of capsid proteins in each fraction by immunoblot analy- 
sis. The HPV16 L1 and HPV 6 L2 were detected in the 
nuclear fractions (lanes 7 and 8 in Fig. 4A and lanes 7 
and 9 in Fig. 4B), whereas no apparent bands of L1 
and L2 were observed in the membrane and cytoplasmic 
fractions (lanes 1-6 in Figs. 4A and 4B). 
Purification and electron microscopic analysis of VLP 
from the yeast 
We purified VLP using sulfato-cellulofine and size-frac- 
tionation chromatography as described under Materials 
and Methods. The 57-kDa band for HPV 16 L1 capsid 
protein was detected in the elution fraction in high salt 
buffer (2 M PBS) (lane 4 in Fig. 5A), whereas it was not 
detected in the flow through fraction (lane 1) and the 
elution fraction in low salt buffer (0.5 M PBS) (lanes 2 
and 3 in Fig. 5A). The same results were observed in HPV 
6 L1 capsid protein. Electron microscopic examination of 
the negatively stained samples showed that the 2 M PBS 
elution samples from the yeast synthesizing HPV 6 L1 or 
HPV 16 L1 contained several virus-like particles (Fig. 
6A) as did that from HPV 6L1/6L2. The L1 protein alone 
seemed to be able to produce VLP. The average size of 
the VLP was 50 nm (40-55 nm) in diameter and pentago- 
nal capsomere structure was apparent. The morpholog- 
ies of these particles were similar to H PV 6 VLP produced 
in a baculovirus system (provided by Martha Ladner and 
Robert Ralston, Chiron Corp., U.S.A.) (Fig. 6E) and native 
viral particles of HPV 1 (Fig. 6F). Many smaller particles 
VIRUS-LIKE PARTICLES OF HPV IN YEAST 131 
A M C N B 
(kd)  1 2 3 4 5 6 7 8 9 (kd)  . _ _  
106 _ 106  _ 
80 - -  80  - -  
'~"  L 1 
49.5 - -  49 .5 - -  
32 .5 - -  32 .5 - -  
M C N 
1 2 3 4 5 6 7 8 9 
• 91-- L 2 
FiG. 4. Detection of the capsid proteins in different cell components of Schizosaccharomyces pombe. Ten micrograms of total protein from each 
cell fraction from the different yeast clones was subjected to SDS-PAGE and analyzed by immunoblot with anti-HPV 16 L1 antibody (Camvir-1) (A) 
and anti HPV 6L2 antibody (3F7) (B). M, membrane fraction; C, cytoplasmic fraction; N, nuclear fraction. Lanes 1, 4, and 7, yeast containing HPV 
16 B27L1 and 6L2 genes. Lanes 2, 5, and 8, yeast containing HPV 6 L1 gene. Lanes 3,.6, and 9, yeast containing HPV 6L2 gene. HPV 16 and 6 L1 
proteins (lanes 7 and 8 in Fig. 4A) and HPV 6L2 protein (lanes 7 and 9 in Fig. 4B) are detected in the nuclear fractions as indicated by arrows. 
with diameter about 17 X 23 nm (Fig. 6A) were also 
observed. These smaller particles showing barrel-like 
structures were always copurif ied with the VLP in our 
procedure. The morphology of this particle is very similar 
to a subunit of yeast fatty acid synthase observed in 
Saccharomyces cerevisiae (Stoops et el., 1992). We used 
these particles as an internal control when we compared 
the production level of VLP between individual recombi- 
nant yeast. Some tubular structures were occasional ly 
observed (Fig. 6B). The similar tubular structures have 
been reported to be copurif ied with the viral particles 
from rabbit tissue infected with Shope papi l loma virus 
(Finch et el., 1965) and in human papi l lomaviruses (Ki- 
selev et el., 1969). The surface appearance of the tubular 
structures is very similar to that of the virus particles and 
they are probably composed of similar morphological  
units in a pentagonal array but arranged over the surface 
of a cylinder instead of a sphere. Many smaller particles 
less than 10 nm were also identified in the sample, some 
of which are aggregated (Fig. 60), seem to be unassem- 
bled capsomeres of HPV. All of these particles except 
for the tubular structures were observed in all the sam- 
pies from the other yeast clones, although numbers of 
each particle were different in individual clones. Purer 
samples of VLP were obtained by further purification with 
a gel-filtration column (Figs. 5B and 6D). 
Compar ison of the eff ic iency for capsid sel f -assembly 
in vivo 
To compare the yield of VLP from different capsid pro- 
teins, we counted total numbers of both VLP and fatty 
acid synthase particles in 10 fields at x34,000 randomly 
on the samples which were only purified with a sulfato- 
cellulofine column (Fig. 6A). These results are shown in 
Table 1. Efficiency of each VLP formation in v/vo was 
roughly estimated by the VLP: fatty acid synthase ratio. 
HPV 6 L1, HPV 16 B27L1, and T3LI alone could produce 
24, 68, and 14 times more VLP, respectively, than HPV 
16 PL1. When we compared the yield of VLP between 
L1 alone and L1/L2, approximately four times as many 
VLP were produced in HPV 6 L1/6 L2 than in 6 L1 alone. 
A twofold increase in the yield of VLP was also observed 
in the chimeric clones HPV 16 B27 L1 and HPV 6 L2, but 
A B 
ant i -HPV16 L1 ant i -HPV16 L1 
2 3 4 1 2 3 _ 
- -  ~1--'-16L1 
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F~G. 5. lmmunoblot analyses in the purified samples containing virus-like particles of HPV 16. One milliliter of each sample was tested in these 
experiments. Cell extract from the yeast induced for expression of HPV 16 B27L1 capsid genes was applied into a sulfato-ce/lulofine column and 
several fractions were collected and tested by Western blot analysis with anti HPV 16 L1 antibody (A). Lane 1, flow through fraction; lanes 2 and 
3, two elution fractions in PBS (0.5 M NaCI); lane 4, an elution fraction in PBS (2 M NaCI). The samples purified by sulfato-cellulofine or sulfate- 
cellulofine/gel filtration chromatography were analyzed by Western blot with anti-HPV 16 antibody (left) and with anti-HPV 6 L2 antibody (right) (B). 
The protein markers indicate sizes of 106, B0, and 49.5 kDa (A, the left figure in B), and 80, 49.5, end 32.5 kDa (the right figure in B). Lanes 1 and 
4, total cell extract; lanes 2 and 5, the sample purified with sulfato-cellulofine column; lanes 3 d 6, sample purified with both sulfato-cellulofine 
and gel-filtration columns. 
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Fie. 6. Electron micrographs of purified HPV particles. HPV particles were stained with either uranyl acetate or potassium phosphotungstate and 
examined by TEM. (A) A sample of HPV 6 L1/6 L2 purified with sulfato-cellulofine column. Several virus-like particles (VLP, indicated with black 
closed arrows) and fatty acid synthase molecules (indicated with open arrows). The VLP are 40-55 nm in diameter (scale bar is 100 nm). (B) 
Tubular structures are occasionally seen in the samples and have the same capsomere structure as VLP. (C) Clumps of unassembled capsomeres. 
(D) A sample of HPV 16 B27 VLP obtained by purification with both sulfato-cellulofine and gel-filtration columns. (E) HPV 6 VLP derived from insect 
cells infected with recombinant baculovirus. (F) Native HPV 1 virions. 
VIRUS-LIKE PARTICLES 
TABLE 1 
YIELD OF THE VIRUS-LIKE PARTICLES IN THE RECOMBINANT YEAST 
EXPRESSING DIFFERENT CAPSID PROTEINS 
Number of VLP/ Efficiency of 
Recombinant yeast number of YFASP VLP formation 
expressing capsid (10 fields ~ (No. of VLP X 100/ 
proteins × 34,000) No. of YFASP b) 
H6 L1 68/970 7.01 (24) ° 
H6 L1/L2 225/757 29.7 (100) 
H16 PL1 1/335 0.29 (1.0) 
H16 PL1/6L2 5/1290 0.38 (1.3) 
H16 27L1 326/1672 19.56 (68) 
H16 27L1/6L2 230/650 35.4 (122) 
H16 T3L1 35/849 4.1 (41) 
H16 T3L1/6L2 34/1344 2.7 (9.3) 
~The mean number of particles in 10 fields which was calculated 
from three different preparations is shown. 
Yeast fatty acid synthase particles. 
c Comparative efficiency of production of the virus-like particles (pro- 
tctype L1 of HPV 16 is set at 1.0). 
no stimulatory effect of L2 was observed in HPV 16 PL1/ 
6L2. The yield of the VLP was slightly decreased in the 
T3L1/6L2 compared with that of the T3L1 alone. When 
we examined the expression levels in cell extracts, both 
16 PL1 and 3T L1 proteins were repressed for their ex- 
pression in the chimeric clones PL1/6 L2 and T3L1/6 L2 
(lanes 2 and 6 in Fig. 2A) compared with the PL1 and 
the T3L1 alone (lanes 1 and 5 in Fig. 2A). The stimulatory 
effect of L2 protein to capsid assembly seems to be less 
apparent in yeast than in the other systems (Zhou et aL, 
1991a; Hagensee et aL, 1993; Kirnbauer et aL, 1993). 
Interaction of L1 and L2 proteins in capsid assembly 
The function of L2 protein is not known and there is 
no clear evidence as to whether it is incorporated into 
virus-like particles or not. In our study, the yields of VLP 
of HPV 6 L1 and 16 B27L1 were slightly increased by 
coexpression of HPV 6 L2. The 6 L2 protein comigrated 
with 6 and 16 L1 proteins, when we loaded crude yeast 
lysate onto a gel-filtration column (fractions 5 to 9 in Fig. 
7). However, no 6 L2 band (75 kDa) was detected in 
the VLP samples 6L1/6 L2 and B27L1/6 L2, which were 
purified with an sulfato-cellulofine column or both sulfato- 
cellulofine and gel-filtration columns (lanes 2 and 3 in 
Fig. 5B). No interaction of the L1 and L2 proteins in the 
cell lysate was detected by the coimmunoprecipitation 
assay with either L1 or L2 antibodies (data not shown). 
These findings suggest that the L2 protein was neither 
incorporated into the virus-like particles nor associated 
with the L1 protein in the yeast system. 
DISCUSSION 
We demonstrate that HPV capsid proteins derived from 
fission yeast S. pombe can assemble to form VLP and 
tubular structures as seen in native HPV infection. AI- 
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though some size variation was observed (40-55 rim) in 
these VLP, the size was relatively uniform and the aver- 
age size (50 nm) was similar to the native virion (Finch 
and Klug, 1965; Finch and Crawford, 1975) and the HPV 
16 particles produced in baculovirus systems (Kirnbauer 
et al., 1993). The VLP were also isolated from yeast by 
cesium equilibrium gradient ultracentrifugation (data not 
shown). The buoyant density of the VLP in the gradient 
was 1.29 g/ml, which was the same as that of the HPV 
16VLP (Kirnbauer eta/., 1993) and HPV 33 VLP (Volpers 
eta/., 1994) synthesized in baculovirus systems. All these 
results suggest that the capsid proteins synthesized in 
yeast are similar to that of native HPV and synthetic 
capsid proteins by the other systems. 
In our results, smaller irregularly assembled particles 
were observed in the sample from the yeast expressing 
prototype L1 of HPV 16 (data not shown). Zhou et al. 
(1991a) also first reported that the HPV 16 particles pro- 
duced in a vaccinia virus system were 40 nm in diameter. 
Since their particles were also derived from prototype 
HPV 16, this type seems to form smaller irregularly as- 
sembled particles and this may be correlated with ineffi- 
cient production of the VLP of this type. We introduced 
two L1 variants of HPV 16 (B27L1 and T3L1) into yeast 
and compared them with the prototype L1. The B27 L1 
could produce 68 times more VLP than the prototype 16 
L1 and the T3 L1 produced 14 times more VLP than the 
prototype. These L1 variants share the same mutation at 
residue 202 as the two isolates (114K and 114B) reported 
by Kirnbauer et al. (1993). They reported that the HPV 16 
114KL1 produced about much more VLP than the cells 
expressing the HPV 16 prototype L1 in a baculovirus 
system. The B27 L1 has two amino acid changes at histi- 
dine 202 to aspartate and threonine 266 to alanine (Fig. 
1), whereas the 114K has one amino acid change at 
histidine 202 to aspartate and the 114B has three amino 
acid changes at valine 194 to isoleucine, histidine 202 
to aspartate, and threonine 266 to alanine. From these 
sequences, the B27 L1 seems to be closely related to 
these 114K L1 and 114B L1. Our results therefore support 
the idea proposed by Kirnbauer et aL (1993) that an amino 
acid change at histidine 202 to aspartate is crucial for 
self-assembly of L1 and the sequence with aspartate at 
position 202 may constitute the wild type of HPV 16. 
HPV 16 T3L1 was similar to prototype L1 in some re- 
spects and no stimulatory effect of HPV 6 L2 on capsid 
assembly was observed in 16 PL1/6 L2 or 16 T3L1/6 L2. 
This is probably because the expression levels of PL1 and 
T3 L1 were greatly reduced by coexpression of the L2 
protein (Fig. 2B). Both PL1 and T3L1 proteins become insol- 
uble in PBS suspension when kept at 4 ° for several days, 
while the HPV 6L1 and HPV 16 B27 L1 remained soluble 
(data not shown). A similar finding with the HPV 16 PL1 
was reported by Kirnbauer et al. (1993). The T3 L1 protein 
shared the same mutation at amino acid position 202 as 
the other new isolates of HPV 16, but it has in addition five 
other changes, asparagine 81 to aspartate, aspartate 223 
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FIG. 7. Migration of L1 and L2 proteins by gel-filtration chromatography. One milliliter of the crude cell extract from HPV 6 L1/L2 yeast was applied 
to a Sepharose CL 4B column (1 x 30 cm) equilibrated with PBS. Half-milliliter fractions were collected and run on a SDS-PAGE gel.,The proteins 
were transferred to a membrane which was used for both reactions with anti-L2 and anti-L1 antibodies, Strong signals of L1 (A) and L2 (B) proteins 
indicated by arrows are observed in the same fractions from the first peak which contained VLP (fractions 5-6)  and unassembled capsomeres 
(fractions 7-9), Total cell extract was loaded as control in the last lane of both experiments (CE). 
to glycine, asparagine 327 to serine, alanine 426 to valine, 
and phenyl alanine 446 to serine (Fig. 1). Two nonconserva- 
tive mutations aspartate 223 to glycine and phenyl alanine 
446 to serine may be responsible for an adverse effect on 
self-assembly of this capsid protein. 
Native papillomavirus particles are known to propa- 
gate in the nucleus of the cells infected with the virus. 
However, there is no clear evidence whether nuclear 
localization is essential for self-assembly of the capsid 
proteins generated in in vitro expression systems, al- 
though nuclear localization of the L1 and L2 proteins was 
reported in vaccinia virus systems using HPV 16 (Zhou 
et aL, 1991b) and HPV 1 (Hagensee et a/., 1993). In the 
present study, we also showed that L1 proteins of both 
HPV 6 and HPV 16 were predominantly localized in nu- 
cleus by immunofluorescent staining (Fig. 3) and cell- 
fractionation analysis (Fig. 4). The nuclear staining of 
HPV 6 L1 may represent the nuclear localization of the 
assembled capsid proteins, because it was detected only 
with the neutralizing antibody against HPV 11 which 
cross-reacted with HPV 6 particles by immunogold elec- 
tron microscopy (data not shown). 
At present, the function of L2 protein of papillomavi- 
ruses is not clear. When we expressed both L1 and L2 
proteins of HPV 6 in yeast, slightly more VLP was pro- 
duced than with L1 alone, even in a heterologous system 
(16 B27L1 with HPV 6 L2). Previous reports (Zhou et 
aL, 1991a; Hagensee eta/., 1993; KirnbaueretaL, 1993) 
indicated that coexpression of L2 with homologous L1 
promoted the production of VLP, although the stimulation 
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was different in each case. In some reports (Hagensee 
eta/., 1993; Kirnbauer et al., 1993; Volpers et al., 1994), 
incorporation of L2 proteins into the VLP of HPV 1, HPV 
16, and HPV 33 was suggested, and complex formation 
of L1 and L2 of HPV 16 was also reported by Xi et al. 
(1991), although VLP formation was not observed in that 
report. In contrary, Rose et aL (1993) reported that there 
was no evidence of L1 and L2 complex formation in 
HPV 11 capsid proteins expressed in baculovirus system, 
although the L1- and L2-1abeled proteins were immuno- 
precipitated with cognate antisera. In the present study, 
the L2 protein seems to be neither incorporated in the 
virus-like particles nor associated with L1 protein, be- 
cause no L2 protein (75 kDa) was detected in purified 
VLP and no interaction between the L1 and L2 proteins 
was observed in the coimmunoprecipitation assay. This 
may be the reason why production level of VLP was not 
greatly increased by coexpression of L2 protein in our 
yeast system as compared with the other reports (Ha- 
gensee et al., 1993; Kirnbauer et al., 1993). 
We have shown that preparative amount of VLP could 
be purified by chromatography. The yeast system pro- 
vides an alternative method to produce virus-like parti- 
cles for use as vaccines against human papillomavi- 
ruses. Problems of toxicity, purity, and high cost in other 
systems can be avoided in yeast. The yeast system pre- 
sented here also may be applicable to other viruses for 
particle production and for structural protein analysis. 
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